Alcista
$326.49
Precio del escenario
$295.790
+0.473 (+0.16%)Al cierre
CME Group Inc. provides a derivatives marketplace. The Company enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. It exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural products and metals. It offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. It provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives.
CME Group Inc is a good buy right now due to its strong financial performance and positive market indicators. The current price is $293.87, with a forward P/E ratio of 21.93, indicating reasonable valuation relative to future earnings. The RSI is at 86.08, suggesting strong momentum, although it is in overbought territory. The average analyst price target is $300, with some analysts projecting targets as high as $337, indicating potential upside of approximately 14% from the current price. The main risk is the anticipated Federal Reserve rate hike, which could impact overall market sentiment and lead to volatility.
Morgan Stanley
$337
2026-10-09
Morgan Stanley
2026-10-09
Precio objetivo
$337
Barclays
$281
2026-10-07
Barclays
2026-10-07
Precio objetivo
$281
TD Cowen
$300
2026-10-05
TD Cowen
2026-10-05
Precio objetivo
$300
UBS
$270
2026-10-05
UBS
2026-10-05
Precio objetivo
$270
Wells Fargo
$301
2026-10-01
Wells Fargo
2026-10-01
Precio objetivo
$301
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

CME Group Reports 13% Revenue Growth in Q3 2026

Small Caps and Growth Stocks Lead Market Rally

Midday Trading Highlights for Various Companies

Analysis of Premarket Stock Movements for Multiple Companies

Intensifying Competition in Financial Infrastructure
CME Group Inc. provides a derivatives marketplace. The Company enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. It exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural products and metals. It offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. It provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives. It operates in the Financials sector (SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & industry).
CME Group Inc is a good buy right now due to its strong financial performance and positive market indicators. The current price is $293.87, with a forward P/E ratio of 21.93, indicating reasonable valuation relative to future earnings. The RSI is at 86.08, suggesting strong momentum, although it is in overbought territory. The average analyst price target is $300, with some analysts projecting targets as high as $337, indicating potential upside of approximately 14% from the current price. The main risk is the anticipated Federal Reserve rate hike, which could impact overall market sentiment and lead to volatility.
14 analysts cover CME: 9 rate it Buy, 5 Hold and 0 Sell. The average price target is 285.90.

US regulators want to dismiss the lawsuit filed by CME against crypto perpetual contracts. → Filing submitted on October 16: CME's crypto trading volume rose from 2.66M contracts in May to 3.28M contracts in September (+23%). → CME argues that perpetual contracts are swaps, not futures.
Mostrar más
Here is the rewritten English version: Good news in crypto over the past two days: JPMorgan expanded its JPM Coin deposit token to Ethereum for institutional clients. Visa partnered with Mesh to let users spend crypto directly at 175 million merchant locations. Deutsche Bank is preparing to launch institutional-grade crypto custody services. The CFTC proposed a framework allowing crypto exchanges to opt into federal regulation instead of dealing with state-by-state licensing. CME will launch $BCH Bitcoin Cash and $UNI Uniswap futures. $BNB burned 1.65 million tokens, worth about $1.2 billion. Strategy added another 267 $BTC .
Mostrar más
Cardano's ADA is one of 16 tokens listed as digital commodities in the SEC's March 17 announcement, with the CFTC also participating in that announcement. Bitcoin, ether, and XRP are also on the list, and CME Group has listed ADA futures since February 9. @Cardano
Mostrar más
CME Group listed Uniswap futures on Sunday, October 18, with a trading date of October 19, following self-certification with the CFTC. In the first half of 2026, CME's crypto futures and options open interest averaged $15.4 billion. @Uniswap
Mostrar másEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.